Patents by Inventor Thomas Kieckbusch

Thomas Kieckbusch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10314784
    Abstract: A process for preparing dry powder formulations of a glycopyrronium salt for inhalation that have good stability. The process involves (a) micronising a glycopyrronium salt together with an anti-adherent agent, and (b) admixing carrier particles to form the dry powder formulation.
    Type: Grant
    Filed: December 7, 2015
    Date of Patent: June 11, 2019
    Assignee: Novartis AG
    Inventors: Barbara Haeberlin, Frank Stowasser, Wolfgang Wirth, Anton Baumberger, Stephan Abel, Sebastian Kaerger, Thomas Kieckbusch
  • Publication number: 20160081934
    Abstract: A process for preparing dry powder formulations of a glycopyrronium salt for inhalation that have good stability. The process involves (a) micronising a glycopyrronium salt together with an anti-adherent agent, and (b) admixing carrier particles to form the dry powder formulation.
    Type: Application
    Filed: December 7, 2015
    Publication date: March 24, 2016
    Applicant: Novartis AG
    Inventors: Barbara Haeberlin, Frank Stowasser, Wolfgang Wirth, Anton Baumberger, Stephen Abel, Sebastian Kaerger, Thomas Kieckbusch
  • Publication number: 20150224194
    Abstract: A process for preparing dry powder formulations of a glycopyrronium salt for inhalation that have good stability. The process involves (a) micronising a glycopyrronium salt together with an anti-adherent agent, and (b) admixing carrier particles to form the dry powder formulation.
    Type: Application
    Filed: April 21, 2015
    Publication date: August 13, 2015
    Applicant: Novartis AG
    Inventors: Barbara Haeberlin, Frank Stowasser, Wolfgang Wirth, Anton Baumberger, Stephan Abel, Sebastian Kaerger, Thomas Kieckbusch
  • Publication number: 20120065174
    Abstract: A process for preparing dry powder formulations of a glycopyrronium salt for inhalation that have good stability. The process involves (a) micronising a glycopyrronium salt together with an anti-adherent agent, and (b) admixing carrier particles to form the dry powder formulation.
    Type: Application
    Filed: October 12, 2011
    Publication date: March 15, 2012
    Inventors: Barbara Haeberlin, Frank Stowasser, Wolfgang Wirth, Anton Baumberger, Stephan Abel, Sebastian Kaerger, Thomas Kieckbusch
  • Publication number: 20100266696
    Abstract: A process of preparing a particulate and substantially crystalline drug substance. The process involves suspending a substantially crystalline drug substance in an anti-solvent to give a suspension, homogenising the suspension at elevated pressure to give drug particles that have a mean particle size of less than about 10 ?m, and drying the drug particles to remove any residual anti-solvent.
    Type: Application
    Filed: December 11, 2008
    Publication date: October 21, 2010
    Inventors: Gerhard Muhrer, Thomas Kieckbusch, Ranjit Thakur, Norbert Rasenack, Dilraj Singh, Kurt Schaffluetzel
  • Publication number: 20090209502
    Abstract: A process for preparing dry powder formulations of a glycopyrronium salt for inhalation that have good stability. The process involves (a) micronising a glycopyrronium salt together with an anti-adherent agent, and (b) admixing carrier particles to form the dry powder formulation.
    Type: Application
    Filed: June 28, 2007
    Publication date: August 20, 2009
    Inventors: Barbara Haeberlin, Frank Stowasser, Wolfgang Wirth, Anton Baumberger, Stephan Abel, Sebastian Kaerger, Thomas Kieckbusch